Diversified Healthcare Trust (NASDAQ:DHC) Releases Quarterly Earnings Results

Diversified Healthcare Trust (NASDAQ:DHCGet Free Report) issued its quarterly earnings data on Monday. The real estate investment trust reported ($0.09) earnings per share for the quarter, missing the consensus estimate of $0.12 by ($0.21), FiscalAI reports. The company had revenue of $379.57 million during the quarter, compared to the consensus estimate of $392.89 million. Diversified Healthcare Trust had a negative net margin of 18.59% and a negative return on equity of 15.62%.

Diversified Healthcare Trust Stock Down 0.8%

Shares of NASDAQ:DHC opened at $6.10 on Wednesday. The company has a debt-to-equity ratio of 1.61, a quick ratio of 16.89 and a current ratio of 16.89. Diversified Healthcare Trust has a 52-week low of $2.00 and a 52-week high of $6.85. The business’s 50 day simple moving average is $5.65 and its two-hundred day simple moving average is $4.77. The firm has a market cap of $1.48 billion, a P/E ratio of -5.13 and a beta of 2.43.

Diversified Healthcare Trust Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Thursday, February 19th. Investors of record on Monday, January 26th were paid a dividend of $0.01 per share. This represents a $0.04 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date of this dividend was Monday, January 26th. Diversified Healthcare Trust’s dividend payout ratio is -2.74%.

Insider Activity at Diversified Healthcare Trust

In other news, CEO Christopher J. Bilotto bought 20,000 shares of the stock in a transaction dated Monday, December 15th. The shares were bought at an average cost of $4.89 per share, with a total value of $97,800.00. Following the completion of the transaction, the chief executive officer directly owned 266,285 shares of the company’s stock, valued at $1,302,133.65. This trade represents a 8.12% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 10.06% of the stock is currently owned by corporate insiders.

Institutional Trading of Diversified Healthcare Trust

Several hedge funds have recently bought and sold shares of the business. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its holdings in Diversified Healthcare Trust by 4.4% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 130,756 shares of the real estate investment trust’s stock worth $314,000 after buying an additional 5,544 shares during the last quarter. Goldman Sachs Group Inc. increased its position in shares of Diversified Healthcare Trust by 158.9% during the first quarter. Goldman Sachs Group Inc. now owns 3,862,334 shares of the real estate investment trust’s stock worth $9,270,000 after acquiring an additional 2,370,459 shares in the last quarter. Strs Ohio acquired a new stake in shares of Diversified Healthcare Trust in the 1st quarter worth about $103,000. JPMorgan Chase & Co. lifted its position in Diversified Healthcare Trust by 10.1% in the 2nd quarter. JPMorgan Chase & Co. now owns 923,963 shares of the real estate investment trust’s stock valued at $3,308,000 after acquiring an additional 84,572 shares in the last quarter. Finally, Rhumbline Advisers lifted its position in Diversified Healthcare Trust by 1.9% in the 2nd quarter. Rhumbline Advisers now owns 388,581 shares of the real estate investment trust’s stock valued at $1,391,000 after acquiring an additional 7,084 shares in the last quarter. Institutional investors and hedge funds own 75.98% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages have commented on DHC. B. Riley Financial reaffirmed a “buy” rating and issued a $6.50 price objective (up from $5.50) on shares of Diversified Healthcare Trust in a report on Monday, December 15th. Zacks Research upgraded Diversified Healthcare Trust from a “strong sell” rating to a “hold” rating in a research report on Friday, February 20th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Diversified Healthcare Trust in a report on Wednesday, January 21st. Finally, Royal Bank Of Canada upgraded shares of Diversified Healthcare Trust from an “underperform” rating to a “sector perform” rating and lifted their target price for the stock from $3.00 to $5.00 in a research report on Thursday, November 13th. One research analyst has rated the stock with a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, Diversified Healthcare Trust presently has an average rating of “Hold” and an average price target of $5.75.

Read Our Latest Research Report on Diversified Healthcare Trust

About Diversified Healthcare Trust

(Get Free Report)

Diversified Healthcare Trust is a real estate investment trust (REIT) specializing in the acquisition, ownership and management of healthcare properties across the United States. The company focuses on assets that serve the senior housing and post-acute care sectors, including skilled nursing facilities, assisted living communities, memory care centers and medical office buildings. By partnering with experienced operators, Diversified Healthcare Trust aims to generate stable, long-term cash flows through triple-net leases and percentage rent structures tailored to each property type.

The company’s portfolio spans multiple states and encompasses a mix of single-tenant and multi-tenant properties.

See Also

Earnings History for Diversified Healthcare Trust (NASDAQ:DHC)

Receive News & Ratings for Diversified Healthcare Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Diversified Healthcare Trust and related companies with MarketBeat.com's FREE daily email newsletter.